Bringing Therapies from Bench to Bedside: Navigating Challenges in the Last Mile
Clarify Health
MAY 19, 2020
There is also a looming, time-sensitive reality that biopharma companies face once their products hit the market: they need to recoup the costs of development as quickly as possible before drug patents expire and generics threaten sales. sales, medical science liaisons, etc.).
52 
Let's personalize your content